PT - JOURNAL ARTICLE AU - Khalagi, Kazem AU - Gharibzadeh, Safoora AU - Khalili, Davood AU - Mansournia, Mohammad Ali AU - Samiee, Siamak Mirab AU - Aghamohamadi, Saeide AU - Mir-Mohammad-Ali Roodaki, Maryam AU - Hashemi, Seyed Mahmoud AU - Tayeri, Katayoun AU - Tabar, Hengameh Namdari AU - Azadmanesh, Kayhan AU - Tabrizi, Jafar Sadegh AU - Mohammad, Kazem AU - Hajipour, Firoozeh AU - Namaki, Saeid AU - Raeisi, Alireza AU - Ostovar, Afshin TI - Prevalence of COVID-19 in Iran: Results of the first survey of the Iranian COVID-19 Serological Surveillance program AID - 10.1101/2021.03.12.21253442 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.12.21253442 4099 - http://medrxiv.org/content/early/2021/03/14/2021.03.12.21253442.short 4100 - http://medrxiv.org/content/early/2021/03/14/2021.03.12.21253442.full AB - Background This study aims to estimate the prevalence of COVID-19 in the general population of Iran.Methods The target population was all Iranian people aged six years and older in the country. A stratified random sampling design was used to select 28,314 subjects from among the individuals registered in the electronic health record systems used in primary health care in Iran. Venous blood was taken from each participant and tested for the IgG antibody against COVID-19. The prevalence of COVID-19 was estimated at provincial and national levels after adjusting for the measurement error of the laboratory test, non-response bias, and sampling design.Results Of the 28,314 Iranians selected, 11,256 (39.75%) participated in the study. Of these, 5406 (48.0%) were male, and 6851 (60.9%) lived in urban areas. The mean (standard deviation) participant age was 35.89 (18.61) years. The adjusted prevalence of COVID-19 until August 20, 2020 was estimated as 14.2% (95% uncertainty interval: 13.3%, 15.2%), which was equal to 11,958,346 (95% confidence interval: 11,211,011–12,746,776) individuals. The prevalence of infection was 14.6%, 13.8%, 16.6%, 11.7%, and 19.4% among men, women, urban population, rural population, and individuals ≥60 years of age, respectively. Ardabil, Golestan, and Khuzestan provinces had the highest prevalence, and Alborz, Hormozgan, and Kerman provinces had the lowest.Conclusions Based on the study results, a large proportion of the Iranian population had not yet been infected by COVID-19. The observance of hygienic principles and social restrictions should therefore continue until the majority of the population has been vaccinated.Competing Interest StatementSN and AR are the Minister of Health and Medical Education and Deputy Minister of Public Health of MOHME in Iran, respectively. SMS, SMH, SA, MMR, KT, HNT, JST, and AO have also a position in MOHME. The rest of the authors declare no conflict of interest, real or perceived.Funding StatementThis study was ordered and funded by the Deputy of Public Health of the Iranian Ministry of Health and Medical Education and the National Institute for Health Research of the Islamic Republic of Iran.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the ethics committee of the National Institute of Health Research of the Islamic Republic of Iran (ethics code: IR.TUMS.NIHR.REC.1399.019).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are not available.